Vaxcyte, Inc. PCVX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s other income, net (note 6)?
- Vaxcyte, Inc. (PCVX) reported other income, net (note 6) of -$1.38M in Q1 2026.
- How has Vaxcyte, Inc.'s other income, net (note 6) changed year-over-year?
- Vaxcyte, Inc.'s other income, net (note 6) decreased by 119.4% year-over-year, from $7.14M to -$1.38M.
- What is the long-term trend for Vaxcyte, Inc.'s other income, net (note 6)?
- Over 3 years (2021 to 2025), Vaxcyte, Inc.'s other income, net (note 6) has grown at a 118.2% compound annual growth rate (CAGR), from $3.59M to $37.33M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.